Sorrento Board Rejects Latest Acquisition Proposal
Sorrento Therapeutics, Inc. (SRNE)
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm
Check Earnings Report
US:NASDAQ Investor Relations:
sorrentotherapeutics.com/investors
Company Research
Source: GlobeNewswire
The latest non-binding proposal received on January 9, 2020 from a private equity fund to acquire a majority or all of the issued and outstanding shares of the company for “up to $7.00” per share significantly undervalues the company and is not in the best interest of the shareholders.The board unanimously rejected the acquisition proposal. SAN DIEGO, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced that, after reviewing the latest acquisition proposal in consultation with its advisors, Sorrento’s Board of Directors (the “Board”) determined that the offer significantly undervalues Sorrento and is not in the best interest of the Company’s stockholders. Sorrento’s management continues to execute on the core drug development and to pursue multiple potential strategic alliances and transactions. Accordingly, the Board unanimously rejected the acquisition proposal. About Sorrento Therapeutics, Inc. Sorrento is a clinical stage, anti
Show less
Read more
Impact Snapshot
Event Time:
SRNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRNE alerts
High impacting Sorrento Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRNE
News
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat